P

Prelude Therapeutics Incorporated

72 employees

Prelude Therapeutics is a developer of novel therapies intended to target key drivers of cancer cell growth, survival and resistance.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics
Pharmaceutical
Biopharma

Date founded

2016

Funding rounds raised

Total raised

$60M

from 2 investors over 2 rounds

P

Prelude Therapeutics Incorporated raised $50M on August 24, 2020

Investors: OrbiMed Advisors

P

Prelude Therapeutics Incorporated raised $60M on June 12, 2019

Investors: OrbiMed Advisors

FAQ